Last updated: August 2026
Global rank: Worldwide · 2026-08
#941,362
AI visibility: Grade D
59
SEO health: Latest audit
0
Visits
19.1K
per month, estimated
Keywords
663
ranking in Google
Organic share
100%
19.1K organic visits
LLMS.txt
Published
74 lines AI engines can read
You're seeing the free preview of vir.bio
vir.bio Web Traffic Statistics
Key findings
- Vir Biotechnology (Healthcare, Life Sciences & Wellness) is ranked #941,362 worldwide in our August 2026 domain ranking, up 15,550 places from #956,912 in July 2026.
- It is estimated to receive about 19,100 visits a month from search, 100% of it organic, across 663 ranking keywords.
- Its AI visibility score is 59 out of 100 (grade D), with a published llms.txt of 74 lines.
- Its last technical audit scored 0/100, with "Implement H1 Tags" the highest-priority fix.
| Month | Rank | Move |
|---|---|---|
| August 2026 | #941,362 | ▲ 15,550 |
| July 2026 | #956,912 | ▼ 45,150 |
| June 2026 | #911,762 | — |
| May 2026 | #911,762 | ▼ 284,654 |
| April 2026 | #627,108 | ▲ 119,953 |
| March 2026 | #747,061 | ▼ 97,604 |
| February 2026 | #649,457 | — |
What this company does
Vir Biotechnology focuses on developing treatments that harness the immune system to fight off tough infectious diseases. The team works on novel antibodies and other approaches that target viruses directly while boosting natural defenses. They run multiple clinical programs aimed at conditions like hepatitis B and influenza where current options fall short. Patients dealing with chronic or life threatening infection…
Our read on the site
The SEO health of Vir Biotechnology's website reveals significant areas for improvement, particularly in on-page optimization and technical aspects. Key issues include missing alt attributes for images, a lack of H1 tags, and the absence of a favicon, which collectively hinder accessibility and search engine performanc…
vir.bio Traffic and Visitor Engagement
Search engines send vir.bio an estimated 19,100 visits a month. Effectively all of it is organic — about 19,100 visits from unpaid results. Spread across 663 ranking keywords, that averages roughly 29 organic visits per keyword.
Monthly visits
19.1K
Latest estimate
Change
No monthly history yet
It starts building from the first scan
Organic visits
19.1K
100% of all traffic
Paid visits
0
No paid search detected
Organic vs paid
100%
0%
We don't hold a month-by-month history for this domain yet.
The traffic dashboard builds one from the first scan onwards.
vir.bio AI Visibility
vir.bio scores 59 out of 100 on our AI visibility scale, grade D. It takes full marks for LLMS.txt. The biggest gap is SEO health, at 0 of 20 points (0/100), worth 20 points if closed. It also loses points on Crawlability (0/10), Company profile (19/25) and Structured data (0/5).
Grade D
Scored from this domain's own data — llms.txt, profile completeness, technical health, crawlability and structured data.
Present
6/8 core fields
0/100
robots ✗ · sitemap ✗
Not detected
Fix these first
- → Complete your company profile so AI answers about you stay accurate.
- → Add robots.txt and sitemap.xml so AI crawlers can read you.
vir.bio LLMS.txt
The llms.txt on vir.bio runs to 74 lines (4,173 characters) across 12 sections, last generated in May 2026. It introduces the site as "Vir Biotechnology". It tells AI engines the business works in Biotechnology, Immunotherapy and Infectious Diseases. It describes 3 products, including VIR-2218, VIR-3434 and VIR-2482. Services it lists include Clinical Trial Support and Antibody Discovery. Technologies it mentions include Antibody Engineering Platforms and siRNA Technology. The keywords it claims start with "biotechnology", "infectious diseases", "clinical trials" and "patient outcomes". It gives the company type as Public.
Status
Published
AI engines can read it
Lines
74
In the file
Size
4.2K
Characters
Sections
12
Updated May 25, 2026
What the file says
# Vir Biotechnology ## About Vir Biotechnology focuses on developing treatments that harness the immune system to fight off tough infectious diseases. The team works on novel antibodies and other approaches that target viruses directly while boosting natural defenses. They run multiple clinical programs aimed at conditions like hepatitis B and influenza where current options fall short. Patients dealing with chronic or life threatening infections stand to benefit most from their pipeline. The company partners with leading research institutions to move discoveries from lab bench to bedside faster. Their approach emphasizes precision so therapies hit the intended target without broad side effects. Early trial data has shown promising signs in improving patient outcomes for hard to treat cases. Investors have backed the work because of the clear unmet need in infectious disease medicine. Leadership brings deep experience from both biotech startups and big pharma environments. The strategy centers on building a sustainable portfolio rather than chasing single blockbuster drugs. Collaboration with contract research organizations helps manage the heavy lifting of large scale trials. Regulatory pathways for biologics require careful navigation and the company has assembled specialists for that. Real world evidence from ongoing studies feeds back into refining their candidates. They a
Sections in the file
Areas of work
Keywords it claims
Technologies
Products it tells AI about
- VIR-2218Contact for pricing
- VIR-3434Contact for pricing
- VIR-2482Contact for pricing
Services it tells AI about
- Clinical Trial Support
- Antibody Discovery
Competitors it names
Company type
Public
vir.bio Organic Keywords
Google lists vir.bio for about 663 keywords, which together bring an estimated 19,100 organic visits a month.
Ranking keywords
663
Found in Google for this domain
Visits they bring
19.1K
Estimated organic visits a month
Top ranking keywords
No ranked-keyword data cached for this domain yet.
Ranked Keywords pulls the full list on its first run.
What it ranks for
vir.bio SEO Audit
The latest technical audit of vir.bio scored 0 out of 100 overall. The audit makes 20 recommendations in all, and 4 of the 4 listed first are rated high priority or critical.
Overall
SEO
Performance
Accessibility
Fix these first
- CriticalImplement H1 Tags
- HighAdd Alt Text to Images
- CriticalCreate a Sitemap.xml
- HighAdd Robots.txt File
16 more recommendations, with the exact changes and the pages they apply to, are in the full report.
vir.bio Competitors and Alternatives
Vir Biotechnology's company profile names https://www.gilead.com, https://www.amgen.com, https://www.regeneron.com and https://www.bristolmyerssquibb.com as competitors. Its own llms.txt adds https://www.janssen.com and https://www.merck.com. Outside its market, the domains ranked closest to it in our worldwide ranking are anfsupplies.com, seduniaselat.com, mwglforums.com and seeamovie.org.
vir.bio Company Profile
Vir Biotechnology focuses on developing treatments that harness the immune system to fight off tough infectious diseases. The team works on novel antibodies and other approaches that target viruses directly while boosting natural defenses. They run multiple clinical programs aimed at conditions like hepatitis B and influenza where current options fall short. Patients dealing with chronic or life threatening infection…
Founded in 2016 (about 10 years ago), Vir Biotechnology is based in San Francisco, United States. Its workforce is listed as between 201 and 500 employees. Its profile files it under Healthcare, Life Sciences & Wellness, with further tags for Research, Science & Deep Tech; Biotechnology; and Immunotherapy. Total funding on record is $850M. Its tagline reads: "Pushing boundaries in immunotherapy to tackle serious infectious diseases head on".
- Sector
- Healthcare, Life Sciences & Wellness
- Headquarters
- San Francisco, United States
- Founded
- 2016
- Employees
- 201-500
- Revenue
- Not Disclosed
- Funding
- $850M
vir.bio Traffic by Country
Which markets this brand actually serves, and where the web links to it from.
Top customer markets
AI estimate · live webWe only measure visitor geography for domains whose analytics are connected to us. For everyone else this is read live from the web and shown as an estimate — never mixed in with the measured numbers.
No market breakdown available for this brand.
Where its backlinks come from
Measured. The country each linking site is hosted in — a real signal of which regions know this brand.
No backlink sample for this domain yet.
Backlink Analytics collects one on its first run.
vir.bio Backlink Analytics
Who vouches for this domain. Strong, varied links are still the clearest signal of authority — to search engines and to AI engines that cite sources.
We haven't run a backlink crawl for vir.bio yet, so there are no link counts to show. Backlink Analytics builds the profile on its first run and it appears here after that.
—
links on file
Companies ranked next to vir.bio
Neighbours of #941,362 in our worldwide ranking — each with its own report.
Wait — let's zoom out.
You are looking at one domain. vir.bio competes in a market, and the same numbers exist for everyone in it — including the sites AI engines recommend instead of yours. Amrut.ai reads all of them, so you can see who is winning, why, and what to change first.
Everything above, for your own domainand the plan to fix it
Run the free scan on your site and get its AI visibility score, its gaps, and the exact next steps.
Look up another company
A brand name or a domain — the whole overview loads in seconds.